July 21, 2022 News by Marisa Wexler, MS Abortion Bans Are Likely to Restrict Care for MS Patients: Researchers Note: This story was updated on July 25, 2022, for the headline to reflect researchers gave this information in a perspective paper, not a study.Ā Bans on abortion and other reproductive care limitations are likely to have a profound impact on the care of people with multiple sclerosis (MS)…
February 3, 2021 News by Teresa Carvalho, MS New Center to Advance Research on MS, Neurovascular Disorders A $2.5 million donation from the Simon Family Trust is supporting the creation of a new center of expertise to help in the development of new therapies for multiple sclerosis (MS) and other neurological diseases. The new center is being launched by researchers from Gladstone Institutes and the…
October 19, 2020 News by Mary Chapman Eli Lilly Aquires Disarm, Will Develop SARM1 Program for Axonal Degeneration Eli Lilly has reached an agreement to acquire Disarm Therapeutics, a biotechnology company developing a new class of disease-modifying treatments for patients with axonal degeneration, including those with multiple sclerosis (MS). In its announcement, Lilly committed to advancing Disarm’s prospective therapies, currently in preclinical development.
October 2, 2020 News by Patricia Inacio, PhD MS Patients Should Avoid ‘Silver’ Tooth Fillings Due to Mercury, FDA Advises People with multiple sclerosis (MS) are among theĀ high-risk groups advised to avoid dental amalgams āĀ silver-colored fillings that are 50% mercury ā underĀ new recommendations issued by theĀ U.S. Food and Drug AdministrationĀ (FDA). Amalgams can be used by dentists to restore the structure and surfaces of teeth damaged by decay.
September 23, 2020 News by Teresa Carvalho, MS Siemens Healthineers, Novartis Partner to Develop NfL Diagnostic Test The development of a diagnostic test using neurofilament light chain (NfL) ā a biomarker for nerve cell damage ā for people with multiple sclerosis (MS) will be part of a collaboration program between Siemens HealthineersĀ and Novartis. The goal of this new collaboration is to design, develop,…
January 31, 2020 News by Ana Pena PhD FDA OKs Device to Monitor Blink Reflex, Potential Way of Detecting MS Early EyeStat, a portable device to measure blink reflex, has been cleared for use by the U.S. Food and Drug Administration (FDA). On the heels of promising results for assessing brain injury, the manufacturer, Blinktbi, plans to test if the device can be used for the early detection…
December 9, 2019 News by Marisa Wexler, MS Atlas Biotechnologies to Fund Research into Cannabis Treatment for MS, Similar Diseases Atlas BiotechnologiesĀ will fund and provide support to three research projects at the University of AlbertaĀ to possibly identify cannabis component(s) that could help people with neurological diseases likeĀ multiple sclerosis (MS). The cannabis plant produces hundreds of biological compounds, the best-known being tetrahydrocannabinol (THC) ā the psychoactive compound primarily…
December 4, 2019 News by Catarina Silva CMSC Joins NeurologyLive Program for Specialists Caring for Those with MS, Like Diseases NeurologyLive, a platform for healthcare specialists, has added The Consortium of Multiple Sclerosis Centers (CMSC) to its Strategic Alliance Partnership program that works to share insights and experiences to benefit people with multiple sclerosis (MS) and their families. A collaborative mix of neurological centers, networks, and…
November 15, 2019 News by Joana Carvalho, PhD Weill Neurohub Unites 3 Academic Centers with DOE Scientists to Advance Tools, Treatments for MS and Other Ills Three academic research institutions launched the Weill Neurohub initiative, an effort to speed the discovery and development of therapies forĀ neurological diseases thatĀ includeĀ multiple sclerosis (MS), Parkinsonās and Alzheimerās disease, and for psychiatric disorders like anxiety, depression, and schizophrenia. The initiative unites three West Coast…
August 19, 2019 News by Marisa Wexler, MS NHS ‘Toolkit’ Aims to Improve Care Given People with MS, Other Neurological Ills in UK The National Health Service (NHS) EnglandĀ announced an initiative that aims to speed diagnoses and ensure better all-around care for people with progressive neurological conditions like multiple sclerosis (MS), Parkinson’s disease, and motor neuron disease (MND). Experts at NHS England, as part of the NHS RightCare…
August 2, 2019 News by Steve Bryson, PhD Rewind Therapeutics Receives Research Grant to Develop New Remyelination Medicines for MS The development of new medicines to treat myelin-related neurological diseases, such as multiple sclerosis (MS), has been given a boost by a ā¬2.9 million (about $3.2 million) research grant awarded to the Belgian biotech company Rewind Therapeutics by…
June 4, 2019 News by Ana Pena PhD AxoSim Licenses Mini-Brain Technology, Which May Speed Therapy Discovery for Neurological Diseases AxoSimĀ has acquired exclusive rights to lab-grown brain miniatures, coined “Mini-Brain,” a technology developed at Johns Hopkins University that uses stem cells to create models of the human brain in a dish. This technique may help speed therapy discovery for many neurological diseases, including multiple sclerosis…
April 29, 2019 News by Alberto Molano, PhD Machine System Based on Brain Activity May Restore Speech to Those Who Lost It, Study Reports A study suggests that it may be possible to create synthetic speech based on recordings of brain activity in people with irreversible speech loss due to neurological ills, such as multiple sclerosis (MS), Parkinson’s, or stroke. The system uses tiny electrodes implanted on the surface of the brain thatĀ directly records…
March 5, 2019 News by Jonathan Grinstein #ACTRIMS2019 – Stem Cell Tourism Poses Threat of Complications for Patients, First US Neurologist Survey Says Academic neurologists are seeing many patients with neurological diseases interested in or receiving unapproved stem cell-based treatments, sometimes with negative health and/or financial consequences, according to a U.S. survey of neurologists. The data were reported byĀ Wijdan Rai, MD, from Ohio State University in aĀ poster titled āComplications of Stem Cell…
February 14, 2019 News by Jonathan Grinstein FDA Asked to Place Cannabis-based Therapy for Progressive MS on Fast Track, MMJ Holdings Says A request for a potentialĀ cannabis-based treatmentĀ forĀ multiple sclerosisĀ to be givenĀ Fast Track designation, speeding its development as it readies to enter clinical testing, is now before theĀ U.S. Food and Drug Administration (FDA), MMJ International HoldingsĀ announced. MMJ-001, as this lead candidate is known, aims to treat…
February 4, 2019 Columns by Debi Wilson Is There a Connection Between Fibromyalgia and MS? I’ve often wondered if there may be a connection between fibromyalgia, multiple sclerosis (MS), and other neurological conditions. BackĀ in the early 1990s, my doctor suspected fibromyalgia as the culprit for my fatigue, aches, and pains. At the time, doctors diagnosed fibromyalgia by the use of tender points.
October 3, 2018 News by Mary Chapman NMSS Praises Federal Funding of Data Collection for MS, Other Diseases A new U.S. law designed to update and expand data on Americans with multiple sclerosis (MS) and similar illnesses will significantly advance disease research, said the National Multiple Sclerosis Society (NMSS). The spending bill, signed into law Sept. 28 by President Trump,Ā provides $5 million to the Centers for…
January 5, 2018 News by Patricia Inacio, PhD Human Herpes Virus 6 May Increase Risk of MS, Study Suggests Iranian researchers have identified another herpes virus that may increase the risk of a person developing multiple sclerosis. The team identified the human herpesvirus 6, or HHV6, as a potential risk factor for MS through a meta-analysis of several studies. They published their findings, āRelationship of Human…
January 26, 2017 News by Patricia Silva, PhD Flex Pharma Shifts Focus to Programs Targeting MS, Other Neurological Diseases Flex PharmaĀ said it plans toĀ prioritize developing its clinical programs in neurological diseases, including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and peripheral neuropathies like Charcot-Marie Tooth (CMT). One or two proof-of-concept, Phase 2 clinical trials are planned for this year in the United States to evaluate Flex Pharmaās…
December 19, 2016 News by Patricia Silva, PhD 9 Research Teams at Virginia Universities Awarded Grants into Studies of Brain Nine research teams at the University of VirginiaĀ and Virginia TechĀ will be awarded grants totalingĀ $550,000 for studies addressing issues related to brain development and brainĀ function in health and disease. Among theĀ university-fundedĀ projects receiving between $50,000 and $70,000 each is research into potentialĀ new treatmentsĀ for multiple sclerosis. āWe are planting seeds that…
November 22, 2016 News by Patricia Silva, PhD RSNA 2016: Philips to Debut Advanced Software Applications to Evaluate Neurological Disorders Royal PhilipsĀ willĀ introduce a new suite of magnetic resonance (MR)-based software applications at the upcomingĀ Radiological Society of North Americaās 102ndĀ Scientific Meeting and Annual Assembly (RSNA 2016;Ā #RSNA16) Nov. 27 to Dec. 2 in Chicago. Philipsā Ingenia family of digital MRI systemsĀ provides radiologists with a unique set…
September 13, 2016 News by Patricia Silva, PhD Gladstone Scientist Wins $5.8M NINDS Award for Work in MS and Neurological Diseases Katerina Akassoglou, PhD, a Gladstone Institutes senior investigator, has been awardedĀ a multiyear, $5.8 millionĀ career grant from the National Institute of Neurological Disorders and Stroke (NINDS) for her work on neurological diseases, including multiple sclerosisĀ (MS). The Gladstone Institutes is a nonprofit community of scientists, affiliated with the…
February 18, 2016 News by Patricia Silva, PhD US Moves Step Closer to National MS, Neurological Disease Registry with Senate Panel Vote The U.S. Senate health committee recently passed the āAdvancing Research for Neurological Diseases Act of 2015ā (S. 849), sponsored by Sens.Ā Johnny IsaksonĀ and Chris Murphy, whichĀ wouldĀ create a nationwide system to track the incidence and prevalence of neurological diseases, including multiple sclerosis (MS), and thatĀ one day might help lead to a…